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Objective: To evaluate the effectiveness of uterine artery embolization (UAE) for treating symptomatic fibroids with high 
signal intensity (SI) on magnetic resonance (MR) T2-weighted imaging (T2WI).
Materials and Methods: A total of 537 cases, consisting of 14 patients with high SI fibroids on T2WI (T2 high group), were 
retrospectively included and compared with 28 randomly selected patients with low SI fibroids on T2WI (control group). 
High SI of a predominant fibroid on T2WI was defined as having the same or higher SI than the myometrium. Patient ages 
ranged from 28 to 52 years (mean, 38.1 years). All patients underwent MRI before and after UAE. Predominant fibroid and 
uterine volumes were calculated with MR images. Symptom status in terms of menorrhagia and dysmenorrhea was scored on 
a scale of 0-10, with 0 being no symptoms and 10 being the baseline, or initial symptoms.
Results: Of the patients in the T2 high group, 13 out of 14 (92.9%) patients demonstrated complete necrosis of the 
predominant fibroids. The mean volume reduction rates of the predominant fibroids in the T2 high group was 61.7% at 
three months after UAE, which was significantly higher than the volume reduction rates of 42.1% noted in the control 
group (p < 0.05). Changes in symptom scores for menorrhagia and dysmenorrhea after UAE (baseline score minus follow-up 
score) were 4.9 and 7.5 in T2 high group and they were 5.0 and 7.7 in control group, suggesting a significant resolution of 
symptoms (p < 0.01) in both groups but no significant difference between the two groups.
Conclusion: UAE is effective for uttering fibroids showing high SI on T2WI. The mean volume reduction rate of the 
predominant fibroids three months after UAE was greater in the T2 high group than in the control group.
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INTRODUCTION
Uterine artery embolization (UAE) has recently been 
applied to the management of symptomatic leiomyomas and 
is rapidly gaining acceptance as an effective alternative to 
a hysterectomy and myomectomy (1, 2). Despite extensive 
clinical experience in UAE, patient selection is a complex 
process influenced by presenting symptoms, physical 
examination, imaging findings, and patient preferences. 
Therefore, it is important to verify the presence of uterine 
leiomyomas to confirm whether the leiomyomas are causing 
the main symptoms, and to determine specific anatomic 
criteria, such as leiomyoma size, location, morphology, 
degeneration and vascularity, which may affect patient 
outcomes (3).
Signal intensity (SI) of leiomyomas on T2-weighted 
imaging (T2WI) is a major factor in predicting responsive or 
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unresponsive tumors depending on the treatment modality 
(4-6). However, the study of UAE effectiveness with respect 
to leiomyomas with high SI on T2WI is scant, where a 
high SI fibroid on T2WI can be defined as having the 
same or higher SI than that of the myometrium or skeletal 
muscle (7). A high SI of the fibroid on T2WI may represent 
high cellularity, proliferative activity as well as increased 
vascularity, and those fibroids may demonstrate a better 
response to UAE (8-10).
The purpose of the current study was to evaluate the 
effectiveness of UAE for treating symptomatic high SI 
fibroids on T2WI.
MATERIALS AND METHODS
The institutional review board gave approval for the entire 
study, and each patient gave written informed consent. 
All patients who underwent UAE for symptomatic fibroids 
between August 2007 and July 2010 were analyzed. Among 
the 537 cases, a total of 14 patients with high SI fibroids 
on T2WI (T2 high group) were retrospectively enrolled in 
the study. A computerized random number generator was 
used to select two times as many patients from the control 
group than the T2 high group. A total of 28 patients with 
low SI fibroids on T2WI (control group) were randomly 
selected for comparison. A high SI predominant fibroid on 
T2WI was defined as having the same or higher SI than 
that of the myometrium, a low SI; lower SI than that of the 
normal myometrium. Patients who demonstrated high SI on 
T2WI without contrast enhancement, which is considered 
indicative of a degenerative fibroid and is contraindicated 
for UAE, were excluded from the study. Patient ages ranged 
from 28 to 52 years (mean 38.1 years). The median follow-
up period was 7.5 months (range; 3-30 months).
Magnetic Resonance Imaging Studies
All magnetic resonance (MR) images were analyzed by 
two experienced radiologists, by consensus. All patients 
underwent a preprocedural MRI (1.5-T Signa HD/HDx; GE 
Healthcare, Waukesha, WI, USA) of the pelvis. Axial and 
sagittal fast spin echo T2WI (TR/effective TE, 4400/120; 
matrix size, 384 x 224; field of view, 300 x 300 mm; section 
thickness, 5 mm) and contrast-enhanced sagittal T1-
weighted imaging were performed in all cases. Enhanced 
MRI (TR/TE, 766/9; flip angle 90°; matrix size, 256 x 
160; field of view, 300 x 300 mm; section thickness, 5 
mm) was performed 2 minutes after intravenous infusion 
of 10 mL gadolinium (Dotarem, Guerbet, Auckland, New 
Zealand). Necrosis was defined as the absence of contrast 
enhancement on T1-weighted imaging. The total volume 
of the predominant fibroids and uterus was determined by 
measuring the length, height, and width and calculating 
the volume with use of the equation for a prolate ellipse: 
length x width x height x 0.5233 (11).
Follow-up consisted of an outpatient visit, where a 
questionnaire interview was conducted followed by an MRI; 
3 months after UAE in all patients. Patients were assessed 
for the extent of fibroid volume reduction as well as fibroid 
necrosis after UAE by a 3-month follow-up MRI.
Arteriography and Embolization
Unilateral right femoral artery access was used in all 
cases. A 5.0 Fr RHR catheter (Cook, Bloomington, IN, USA) 
was placed in the internal iliac artery, and a coaxial 3 Fr 
microcatheter (MicroFerret; Cook, Bloomington, IN, USA) 
was advanced distally into the uterine artery. Embolization 
was performed with the catheter tip beyond the origin of 
the cervicovaginal branch. The primary embolic agent was 
non-spherical polyvinyl alcohol (PVA) particles (Contour; 
Boston Scientific, Natick, MA, USA) mixed with 60 mL of 1 : 
1 saline solution : contrast agent mixture. The choice of PVA 
size was based on operator preference; 250 to 355 μm or 
355 to 500 μm of PVA particles were used initially, followed 
by 355 to 500 μm or 500 to 710 μm particles. Embolization 
was performed until complete cessation of blood flow 
was achieved in the ascending uterine artery during ten 
cardiac beats. Intravenous administration of 30 mg of 
ketorolac tromethamine was performed at the moment the 
first uterine artery was catheterized. Pain after UAE was 
managed via an intravenous patient-controlled analgesic 
pump containing 500 μg of fentanyl sulfate and 90 mg of 
ketorolac tromethamine mixed with 50 mL of normal saline. 
Clinical Follow-Up
A symptom severity questionnaire was administered in 
order to assess the severity of menstrual bleeding and 
dysmenorrhea during and between menstrual periods on a 
scale from 0 (no impact) to 10 (severe impact) at the time 
of the three-month follow-up MR imaging study.
Statistical Analysis
A t test and Fisher’s exact test were used to compare 
the effects of UAE on volumes of predominant fibroids and 
clinical outcomes between the two groups. A paired t test 
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was used to determine the effects of UAE in each group. 
Differences were considered to be statistically significant at 
p < 0.05.
Data analyses were performed with the SPSS statistical 
software (SPSS, version 12; SPSS, Chicago, IL, USA). 
RESULTS
The baseline characteristics of the leiomyomas are 
summarized in Table 1. 
Among the 537 patients who underwent UAE, 14 (2.6%) 
had fibroids with high SI on T2WI; there were no technical 
failures resulting from an inability to catheterize the uterine 
artery. Moreover, there were no statistically significant 
differences with respect to age or mean diameters and 
volumes of predominant fibroids before UAE between the 
T2 high group and the control group. In the T2 high group, 
only one patient had a fibroid with a SI equal to that of the 
myometrium, while the remaining 13 demonstrated fibroids 
with a higher SI than normal myometrium
Cramping pain occurred in all patients after UAE and was 
managed via an intravenous patient-controlled analgesic 
pump. Pain began to subside approximately 8-10 hours 
after UAE, and all patients were able to be discharged the 
next day and completely recovered after 1-2 weeks. 
 With regard to treatment effects, 13 (92.9%) of 14 
patients from the T2 high group demonstrated complete 
necrosis of predominant fibroids (Fig. 1), which was not 
statistically significant when compared with 27 (96.4%) 
of 28 patients in the control group. Two patients showed 
incomplete necrosis of the fibroids, one in each group, 
respectively. One patient in the control group had a 4.5 
cm submucosal myoma, which was reduced to 1.3 cm 
after UAE. However, the viability of the fibroid was still 
seen, and a hysteroscopic resection was recommended, 
but the patient refused any further procedure. The other 
patient in the T2 high group had multiple myomas, and 
the predominant fibroid was located in the lower uterine 
segment. Multiple myomas in the uterine body revealed 
complete necrosis after UAE, but a predominant fibroid in 
the lower uterine segment was not devascularized. Surgery 
was recommended, but the patient refused. One patient 
who had undergone a myomectomy three times before UAE 
demonstrated an 80% volume reduction after UAE, where 
the pathologic exam before UAE revealed extensive edema 
and increased vascularity in a specimen of myomectomy 
(Fig. 2). Spontaneous vaginal expulsion of the predominant 
fibroid occurred in one patient in the T2 high group and in 
two patients from the control group. The pathologic exam 
performed on the patient in the T2 high group revealed 
infarcted leiomoyma (Fig. 3). 
The mean volume of the predominant fibroids in the T2 
high group decreased by 61.7% at three months, from 144.4 
± 97.4 cm3 to 55.3 ± 51.3 cm3, which was significantly 
higher than the volume reduction rates of 42.1%, from 
141.0 ± 50.8 cm3 to 81.6 ± 22.7 cm3, noted in the control 
group (p < 0.001). 
The mean volume of the uterus in the T2 high group and 
in the control group decreased by 47.1% (from 399.0 cm3 
± 143.6 to 208.6 cm3 ± 87.0) and 38.8% (from 407.0 cm3 
± 239.8 to 244.7 cm3 ± 144.6), respectively, but did not 
decrease significantly.
Clinical outcomes are summarized in Table 2. Symptom 
improvements were reported with respect to menorrhagia 
and dysmenorrhea after UAE. Changes in symptom scores 
(baseline score minus follow-up score) for menorrhagia and 
Table 1. Baseline Characteristics and Outcomes after Uterine Artery Embolization
T2 High Group (n = 14) Control Group (n = 28) P
Age 37.2 38.6 > 0.05*
Mean size of F1 (cm) 7.1 6.9 > 0.05*
Mean volume of F1 (cc) 144.4 141.0 > 0.05*
Complete necrosis of F1 13 (92.9%) 27 (96.4%) > 0.05†
Mean VRR (%) of F1
  three months after UAE
61.7 42.1 < 0.05*
Mean VRR (%) of the uterus
  three months after UAE
47.1 38.8 > 0.05*
Vaginal expulsion of F1 1 (7.1%) 2 (7.1%) > 0.05†
Note.— Values are given as n (%). *t test, †Fisher’s exact test. F1 = Predominant fibroid, VRR = volume reduction rate, UAE = 
uterine artety embolization
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dysmenorrhea were 4.9 and 7.5 in the T2 high group , 5.0 
and 7.7 in the control group, respectively, representing 
a significant resolution of symptoms (p < 0.01), but no 
statistically significant differences between the two groups 
(p > 0.05). Mid-term follow-up MRI in three patients 
revealed persistent necrosis of the fibroids with further 
shrinkage of the fibroids. Symptoms were continuously 
relieved at mid-term follow-up. A single major complication 
was found in one patient with an 8-cm fibroid in the 
T2 high group, and was readmitted for pain control and 
conservative management for three days. 
DISCUSSION
Since MR imaging more accurately detects and 
characterizes pelvic pathologies such as adenomyosis, 
including its soft tissue characterization, multiplanar 
imaging capabilities, and dynamic enhancement potential, 
A
D
B C
Fig. 1. 36-year-old woman with uterine leiomyoma. 
A. Sagittal T2-weighted magnetic resonance (MR) image demonstrates 6.2-cm uterine leiomyoma 
with high signal intensity. B. Gadolinium-enhanced T1-weighted MR image corresponding to (A) 
contrast enhancement of fibroid is demonstrated (arrows). C. T2-weighted MR image obtained 
three months after embolization reveals 40% volume reduction of leiomyoma (arrows). D. 
Gadolinium-enhanced T1-weighted MR image corresponding to (C) complete necrosis (arrows) 
of fibroid focal hemorrhage (arrowhead), which is also noted as high signal intensity on non-
contrast T1- weighted image (not shown) are demonstrated.
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it is now an established diagnostic modality as well as 
a treatment planning tool before UAE (14-16). In one 
study, MR imaging changed the initial diagnoses in 18% 
of patients, and immediate clinical management in 22% of 
patients (17).
Leiomyomas with the same collagen content as normal 
myometrium tend to have an SI almost equal to that of 
myometrium. When the collagen fiber content increases, 
the SI decreases, especially on T2WI (8). Leiomyomas 
with increased signal intensity on T2WI have a tendency 
to show a high degree of both cellularity and proliferative 
activity. Cellular leiomyomas, which are composed of 
compact smooth muscle cells, have relatively higher SI 
on T2WI and may demonstrate enhancement on contrast-
enhanced images. Like a case in our study, extensive 
edema in the interstitial space is also a reason for high 
SI on T2WI with marked enhancement (9). In cases of 
rare myxoid leiomyomas, MR imaging shows that tumors 
contain abundant myxoid material between smooth muscle 
cells. The myxoid portion has high signal intensity on 
T2WI and enhances well except for small foci of mucinous 
lakes or clefts. Delayed and prolonged enhancement is 
seen because of the presence of a myxoid stroma (16). 
Degenerated leiomyomas have a variable appearance on 
T2WI. Leiomyomas with hyaline or calcific degeneration are 
generally low in SI, whereas those with cystic degeneration 
A
D
B C
Fig. 2. 39-year-old woman with history of myomectomy on three 
previous occasions. 
A. Sagittal T2-weighted magnetic resonance (MR) image demonstrates 
9.2-cm uterine leiomyoma with high signal intensity. B. Gadolinium-
enhanced T1-weighted MR image reveals uterine leiomyoma with contrast 
enhancement (arrows). C. T2-weighted MR image obtained three months 
after embolization reveals 80% volume reduction of fibroid (arrows). D. 
Histologic examination (original magnification x 100; hematoxylin-eosin 
stain) in specimen of myomectomy before embolization shows leiomyoma 
with extensive edematous stroma (arrowheads) and prominent blood 
vessels (arrows), suggesting increased vascularity.
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are generally very high in SI. However, the cystic areas do 
not enhance well and can be distinguished from other types 
of leiomyomas. 
The SI of leiomyomas on T2WI has been regarded as an 
important factor in considering patient selection for various 
treatment modalities. High SI leiomyomas with high SI on 
T2WI are not appropriate for MR-guided focused ultrasound, 
in which 20% more patients with fibroids showing high 
SI receive reinterventional treatment at two years than 
those with low SI myomas (4). However, high SI fibroids 
are expected to be responsive to gonadotrophin-releasing 
hormone agonists (5, 6).
Only a few studies with UAE treatment for fibroids 
with high SI on T2WI with clinical outcomes have been 
reported to date (10, 18). Burn et al. (10) reported that 
leiomyomas with a high signal intensity on T2WI were 
predictive of a good prognosis. deSouza et al. (18) found 
that leiomyomas with a high SI on initial T2WI showed a 
significantly greater volume reduction of 55.8% than those 
with a low SI (32.5%). Both studies enrolled patients with 
multiple fibroids; 18 patients with 32 leiomyomas and 11 
patients with 45 leiomyomas, respectively. However, others 
reported no correlation between T2WI SI and leiomyoma 
volume reduction after UAE (19, 20). Most studies regarding 
fibroids and T2WI SI have included multiple myomas in each 
patient.
According to Harman’s study, volume reduction of the 
fibroid after UAE was more prominent in fibroids that had 
a marked contrast enhancement on T1-weighted images 
as well as a high SI on T2WI. They concluded that the 
increased contrast enhancement of a fibroid is indicative 
of a lesion with increased vascularity and is expected to be 
predictive of a better response. 
Recently, Hecht et al. (19) suggested that the apparent 
diffusion coefficient (ADC) of leiomyomas can be used 
to predict volumetric response following UAE. In their 
study of 11 patients with 28 leiomyomas, they suggested 
a significant correlation between the volume reduction of 
fibroids and ADC, but no correlation with relative T2WI 
SI. One possible reason for the discrepancy regarding the 
correlation between the volume reduction of the fibroid and 
T2WI SI may be that multiple fibroids including small ones 
in each patient were enrolled, which sometimes can lead 
to errors in the measurement of fibroid sizes. In contrast, 
our study enrolled only predominant fibroids with high SI 
on T2WI in each patient and compared them with low SI 
fibroids; this comparison demonstrated a significant volume 
reduction of the predominant fibroid. 
Symptoms of menorrhagia and dysmenorrhea were 
considerably improved after UAE, indicating that UAE for 
fibroids with high SI on T2WI was effective for controlling 
symptoms as well as fibroid volume reduction. However, 
one limitation of our present study was the small number 
of patients; further studies with a larger population size are 
needed. 
In conclusion, UAE was effective for treating fibroids with 
high SI on T2WI. The mean volume reduction rate three 
months after UAE was greater in the T2 high group than in 
the control group. 
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